Has Convalescent Plasma Therapy Hesitancy Increased COVID-19 Mortality?

Area of Science:

• * Infectious Diseases
• * Immunology
• * Critical Care Medicine

Background:

• * The coronavirus disease 2019 (COVID-19) pandemic necessitated rapid development of therapeutic strategies.
• * Convalescent plasma therapy (CPT) emerged as a potential treatment option.
• * Evidence review and data interpretation are crucial for optimizing CPT use.

Purpose of the Study:

• * To provide a viewpoint on the journey of convalescent plasma therapy (CPT) in managing COVID-19.
• * To discuss the optimal utilization of updated CPT data.
• * To maximize patient benefits and save lives, particularly in resource-constrained environments.

Main Methods:

• * Review and synthesis of existing data on convalescent plasma therapy for COVID-19.
• * Expert opinion and clinical viewpoint on CPT management.
• * Analysis of updated evidence to guide treatment decisions.

Main Results:

• * CPT has been explored as a management strategy during the COVID-19 pandemic.
• * Updated data provides insights into the efficacy and application of CPT.
• * Strategic use of CPT can enhance patient outcomes.

Conclusions:

• * Convalescent plasma therapy remains an important consideration in COVID-19 management.
• * Leveraging updated data is key to maximizing the benefits of CPT.
• * Optimized CPT application can be life-saving, especially in resource-limited settings.